News & Updates

Treatment-resistant hypertension can be monitored using home BP
Treatment-resistant hypertension can be monitored using home BP
27 Jan 2022
Esaxerenone produces favourable night-time BP-lowering effect in Asians
Esaxerenone produces favourable night-time BP-lowering effect in Asians
24 Jan 2022 byJairia Dela Cruz

The novel highly selective mineralocorticoid receptor blocker esaxerenone holds promise in the treatment of nocturnal hypertension, yielding substantial reductions in night-time blood pressure (BP), especially in Japanese patients with a riser pattern, as well as in N-terminal pro B-type natriuretic peptide (NT-proBNP) levels, according to a post hoc analysis of a phase III study.

Esaxerenone produces favourable night-time BP-lowering effect in Asians
24 Jan 2022